gip and glp-1 agonist Frontiers Frontiers | Clinical perspectives on

Tesamorelin Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) under investigation for GH secretagogue activity and visceral adiposity research

The ketogenic diet has demonstrated reductions in triglycerides, improvements in HDL cholesterol, and reductions in small dense LDL particles, the type most associated with cardiovascular risk

Bu LL, Liu YQ, Shen Y, Fan Y, Yu WB, Jiang DL, et al

The new data suggests the problem may be dose-dependent, meaning higher exposure to semaglutide could significantly increase the risk of optic nerve injury

This represents a meaningful quality-of-life improvement even though the underlying structural issue persists